Meds & supplements › Remifentanil
Medicine
ULTIVA is indicated for intravenous (IV) administration: As an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures.
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Remifentanil hydrochloride (HCl) for injection is indicated for intravenous (IV) administration:
The following serious adverse reactions are described, or described in greater detail, in other sections:
Remifentanil HCl is contraindicated:
Table 18 includes clinically significant drug interactions with remifentanil HCl. Table 18: Clinically Significant Drug Interactions with Remifentanil HCl
sofidex [Internet]. Daloreum; c2026. Remifentanil; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/remifentanil
sofidex. (2026, August 3). Remifentanil. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/remifentanil
Remifentanil. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/remifentanil
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.